Management of Hypertensive Emergency with Neurological Manifestations

Immediate Classification and Risk Stratification

The European Society of Cardiology recommends immediate hospitalization for parenteral blood pressure reduction to prevent further end-organ damage, with a target BP reduction of 20-25% within the first hour, avoiding overly aggressive lowering that could worsen cerebral perfusion in the setting of chronic hypertension and prior strokes 1
A patient with acute neurological symptoms, such as giddiness, blurred vision, bilateral internuclear ophthalmoplegia, and gait ataxia, is considered a hypertensive emergency rather than urgency, as evidenced by a blood pressure of 256/121 mmHg 1
New-onset diabetes with osmotic symptoms, such as hyperglycemia, is a significant concern in patients with hypertensive emergencies, and requires careful management to prevent further complications 2
The presence of background multifocal old infarcts and small vessel disease on imaging indicates chronic cerebrovascular disease, requiring cautious blood pressure lowering to prevent further damage 1

The American Heart Association recommends a target blood pressure reduction of 20-25% in the first hour, then gradually to 160/100 mmHg over 2-6 hours, to minimize the risk of cerebral hypoperfusion and stroke extension in patients with prior infarcts 1
Rapid normalization of blood pressure should be avoided, as it risks cerebral hypoperfusion and stroke extension in patients with prior infarcts, and diastolic blood pressure should not be lowered below 60 mmHg in patients with chronic hypertension and cerebrovascular disease 3, 4

The European Society of Cardiology recommends mandatory ICU/monitored bed admission for hypertensive emergency, with continuous intraarterial blood pressure monitoring and neurological assessments every 1-2 hours during the acute phase 1
Intravenous nicardipine is recommended as the first-line agent for blood pressure reduction, due to its potent arteriolar vasodilatory effects and lack of direct myocardial depression 1
Alternative agents, such as intravenous labetalol, may be used if nicardipine is not available or contraindicated, with a recommended starting dose of 20 mg IV over 2 minutes, then 40-80 mg every 10 minutes (maximum 300 mg) 1

The American Diabetes Association recommends insulin infusion protocol targeting gradual glucose reduction to 8-10 mmol/L initially, to prevent further complications and minimize the risk of cerebral edema 2
Rapid glucose correction should be avoided, as it can worsen cerebral edema, and hyperosmolar state should be monitored given polyuria/polydipsia 2

The American Heart Association recommends a target blood pressure of <130/80 mmHg for patients with high cardiovascular risk, such as those with diabetes, prior strokes, and small vessel disease 2, 4, 6
Some evidence supports even lower targets (<120/80 mmHg) in high-risk patients, but diastolic blood pressure should not be lowered below 60 mmHg in patients with cerebrovascular disease 4

The American College of Cardiology recommends avoiding sublingual nifedipine, clonidine, and non-dihydropyridine calcium channel blockers (diltiazem/verapamil) in patients with hypertensive emergencies, due to the risk of unpredictable absorption, excessive blood pressure drops, and increased mortality 3, 4
Terazosin (alpha-blocker) should be reconsidered, as the ALLHAT trial showed increased heart failure risk with doxazosin, and should only be used if other agents are inadequate 3, 4

The European Society of Cardiology recommends intensive outpatient monitoring post-discharge, with weekly blood pressure checks for the first month, and monthly visits until target blood pressure is achieved and maintained 2, 5
Lifestyle modifications, such as sodium restriction <2g/day, weight management (BMI target 18.5-24.9), and regular exercise, should be encouraged to minimize the risk of further complications 2, 6